NPS+ (EU5) [Parkinson's Disease]
本報告基於以150名歐盟5國 (法國·義大利·德國·西班牙·英國)的神經內科醫生為對象所進行訪查之結果，提供8種帕金森氏症治療藥產品之醫生使用趨勢及各種見解之比較分析，以支援測試客戶忠誠度NPS (淨推薦值) 指標的改善。
Neurologists in the EU5 countries are not happy with available Parkinson's disease treatments, and it shows. According to our survey, seven of the eight brands we looked at earned low-and sometimes downright dismal-satisfaction scores. Fortunately, there are things your brand can do to win over more doctors, boost your score, and pick up market share.
Based on a survey of 150 EU5-based neurologists, the report builds on the respected net promoter score (NPS) to compare loyalty for 10 major Parkinson's drugs. Easy-to-use KPIs highlight ways you can improve brand health, while a unique "Brand DNA" section reveals candid insights about your brand.
We surveyed 150 neurologists from the EU5 (France, Italy, Germany, Spain, UK), chosen from the largest community of validated physicians in the world. The same community that pharma market researchers trust for reliable, fast intelligence.
We conducted the survey between January 11th and 16th, 2017.
NPS+ Parkinson's Disease 2017 (EU5) explores key issues affecting brand loyalty for drug manufacturers. You'll learn:
NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.
NPS measures overall brand satisfaction and loyalty by asking one simple question:
"How likely are you to recommend this brand to a colleague?"
Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)-are used to classify respondents into 3 categories:
The percentage of detractors - the percentage of promoters = NPS.
For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.
NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.
NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty.
Each NPS+ report examines doctors' relationships with the brands used to treat a major disease area-measuring brand loyalty and showing you how it affects your market share. NPS+ also examines "brand DNA", revealing in doctors' own words what brands mean to them.
Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next.